Foghorn Therapeutics, Inc. (FHTX)
6.00
-0.22
(-3.54%)
USD |
NASDAQ |
Aug 28, 16:00
6.00
0.00 (0.00%)
After-Hours: 17:48
Foghorn Therapeutics Shareholders Equity (Quarterly) : -81.04M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -81.04M |
| March 31, 2026 | -76.41M |
| December 31, 2025 | -108.50M |
| September 30, 2025 | -89.66M |
| June 30, 2025 | -76.66M |
| March 31, 2025 | -61.65M |
| December 31, 2024 | -45.53M |
| September 30, 2024 | -28.29M |
| June 30, 2024 | -14.32M |
| March 31, 2024 | -97.49M |
| December 31, 2023 | -77.19M |
| September 30, 2023 | -57.39M |
| Date | Value |
|---|---|
| June 30, 2023 | -49.35M |
| March 31, 2023 | -24.59M |
| December 31, 2022 | 0.112M |
| September 30, 2022 | 24.32M |
| June 30, 2022 | 47.63M |
| March 31, 2022 | 72.40M |
| December 31, 2021 | 96.87M |
| September 30, 2021 | 80.98M |
| June 30, 2021 | 104.19M |
| March 31, 2021 | 125.16M |
| December 31, 2020 | 146.19M |
| September 30, 2020 | -133.32M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Prime Medicine, Inc. | 39.81M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 203.39M |
| Total Liabilities (Quarterly) | 284.43M |
| Debt to Equity Ratio | -0.5319 |
| Current Ratio | 3.362 |
| Net Debt Paydown Yield | -0.58% |